AMPK activator · Experimental

AICAR 50mg

AICAR (5-aminoimidazole-4-carboxamide ribonucleoside) · 50mg vial

AICAR is a cell-permeable nucleoside that activates AMP-activated protein kinase (AMPK), the cell's main energy sensor. It is widely used in metabolic and exercise-physiology research.

Pricing · per vial

Mix & match any vials — 2–4 −10%, 5+ −15%
Retail1 vialR600
2–4−10%R540
5+−15%R510

In transit · ETA 24 Nov

How it works

Once inside cells, AICAR is converted to ZMP, which mimics AMP and activates AMPK. This shifts cells toward glucose uptake, fatty-acid oxidation and mitochondrial biogenesis.

Research context

Rodent studies report endurance-like adaptations and metabolic effects, and it drew anti-doping attention as an exercise mimetic. There is no approved human use.

Vial contents & handling

  • 50mg AICAR
  • Single lyophilised vial

Quality & sourcing. Sourced from established manufacturers who test using HPLC analysis. COA available on request — ask us on WhatsApp ↗

Storage: keep unopened lyophilised vials in a cool, dark place. Once reconstituted, store in the fridge at 2–8°C and use within 2 months.

Research reference dosage

50mg vial · 2ml water · 25mg/ml
LevelAmountU100 unitsFrequency
Beginner10mg40 unitsDaily · as per protocol · subq
Intermediate25mg100 unitsDaily · as per protocol · subq
Advanced50mg200 unitsDaily · as per protocol · subq

Fixed 2ml · U100 device (1 unit = 0.01ml). The advanced amount (200 units) requires two syringe fills. Research reference only—not human-use guidance.

Dosing status: No approved dosing. Research protocols vary widely; amounts below are research-reference levels only.

References

Guides

Research use only · Not for human or veterinary consumption · Not for self-administration